Skip to content

Triglyceride-Glucose Index In Heart Failure Patients In Sohag University Hospital

Triglyceride-Glucose Index In Heart Failure Patients In Sohag University Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05663632
Enrollment
200
Registered
2022-12-23
Start date
2022-12-12
Completion date
2023-06-30
Last updated
2022-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Insulin Resistance

Keywords

heart failure, triglyceride-glucose index

Brief summary

study the relationship between Triglyceride glucose index and heart failure patients

Interventions

None listed

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All Heart Failure patients attend to sohag university hospital aged above 18 year old .

Exclusion criteria

* Patients on lipid lowering medications * Patients on antidiabetic drugs * Patients with comorbidities eg liver cirrhosis or malignancy

Design outcomes

Primary

MeasureTime frameDescription
Triglyceride-Glucose Index in Heart Failure Patients6 monthsidentify the relationship between Triglyceride-Glucose Index and heart failure patients in Sohag University hospital

Countries

Egypt

Contacts

Primary ContactAliaa k Khyry, resident doctor
aliaakhairy@med.sohag.edu.eg01067655291
Backup ContactAli T Taha, professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026